Ecuador
A snapshot of PrEP scale-up, registration and resources for Ecuador.

-
200-400Estimated Cumulative Number of People Initiating PrEP
Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.
Data Updated: April 11, 2022
Drug Registration Status
-
Gilead's Truvada (TDF/FTC) registrationApproved
-
Generic versions of TDF/FTC for preventionData not available
-
Viiv’s Apretude (CAB for PrEP) RegistrationNot approved
-
IPM’s Dapivirine Ring RegistrationNot approved
Types of Projects
- Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.